ATE363531T1 - Claudin polypeptide - Google Patents
Claudin polypeptideInfo
- Publication number
- ATE363531T1 ATE363531T1 AT01964084T AT01964084T ATE363531T1 AT E363531 T1 ATE363531 T1 AT E363531T1 AT 01964084 T AT01964084 T AT 01964084T AT 01964084 T AT01964084 T AT 01964084T AT E363531 T1 ATE363531 T1 AT E363531T1
- Authority
- AT
- Austria
- Prior art keywords
- claudin
- methods
- claudin polypeptides
- polypeptides
- treat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22579400P | 2000-08-15 | 2000-08-15 | |
US22551300P | 2000-08-15 | 2000-08-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE363531T1 true ATE363531T1 (de) | 2007-06-15 |
Family
ID=26919667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01964084T ATE363531T1 (de) | 2000-08-15 | 2001-08-15 | Claudin polypeptide |
Country Status (10)
Country | Link |
---|---|
US (1) | US20080254506A1 (de) |
EP (1) | EP1311663B1 (de) |
JP (1) | JP2004519215A (de) |
AT (1) | ATE363531T1 (de) |
AU (2) | AU2001284977B2 (de) |
CA (1) | CA2418725A1 (de) |
DE (1) | DE60128701T2 (de) |
ES (1) | ES2284678T3 (de) |
MX (1) | MXPA03001468A (de) |
WO (1) | WO2002014499A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2833840B1 (fr) * | 2001-12-21 | 2010-06-18 | Rytek | Methodes et compositions pour le traitement de pathologies respiratoires |
FR2833839A1 (fr) * | 2001-12-21 | 2003-06-27 | Rytek | Methodes et compositions pour le traitement de pathologies respiratoires |
US7452877B2 (en) | 2002-03-15 | 2008-11-18 | Rytek | Methods for treating digestive functional pathologies |
FR2837103B1 (fr) * | 2002-03-15 | 2004-07-09 | Rytek | Compositions pour le traitement de pathologies fonctionelles digestives |
FR2844201A1 (fr) * | 2002-09-06 | 2004-03-12 | Rytek | Compositions pour le traitement de pathologies fonctionnelles digestives |
PL375356A1 (en) * | 2002-05-20 | 2005-11-28 | Immunex Corporation | Claudin polypeptides, polynucleotides, and methods of making and use thereof |
FR2844713A1 (fr) * | 2002-09-25 | 2004-03-26 | Exonhit Therapeutics Sa | Nouvelle cible de l'angiogenese et utilisations |
DE10254601A1 (de) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
DE102004023187A1 (de) * | 2004-05-11 | 2005-12-01 | Ganymed Pharmaceuticals Ag | Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie |
DE102004024617A1 (de) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
FR2879100B1 (fr) | 2004-12-09 | 2007-07-06 | Lionel Bueno | Compositions pour le traitement des pathologies oculaires de surface et de la retine |
EP1790664A1 (de) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs |
EP2944694B1 (de) | 2007-10-12 | 2018-07-11 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of Holy and Undiv. Trinity of Queen Elizabeth near Dublin | Verfahren zur öffnung fester verbindungen |
JP5234666B2 (ja) * | 2009-12-11 | 2013-07-10 | 国立大学法人大阪大学 | 乾癬の判定のための測定方法 |
WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
MX369276B (es) | 2012-11-13 | 2019-11-04 | Biontech Ag | Agentes para tratamiento de enfermedades cancerosas que expresan claudina. |
WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
WO2016138245A2 (en) | 2015-02-27 | 2016-09-01 | The Regents Of The University Of Michigan | Claudin-1 peptide reagents and methods |
US10738079B2 (en) | 2017-04-14 | 2020-08-11 | Emory University | Compositions and methods for managing respiratory conditions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999007850A1 (en) * | 1997-08-06 | 1999-02-18 | Millennium Biotherapeutics, Inc. | Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
AU766279B2 (en) * | 1998-10-06 | 2003-10-16 | Curagen Corporation | Novel secreted proteins and polynucleotides encoding them |
JP2003524384A (ja) * | 1998-11-03 | 2003-08-19 | アドヘレックス テクノロジーズ インコーポレイテッド | クラウディン媒介機能を調節するための化合物および方法 |
US20040033493A1 (en) * | 2001-01-31 | 2004-02-19 | Tchernev Velizar T. | Proteins and nucleic acids encoding same |
-
2001
- 2001-08-15 CA CA002418725A patent/CA2418725A1/en not_active Abandoned
- 2001-08-15 EP EP01964084A patent/EP1311663B1/de not_active Expired - Lifetime
- 2001-08-15 JP JP2002519627A patent/JP2004519215A/ja active Pending
- 2001-08-15 AT AT01964084T patent/ATE363531T1/de not_active IP Right Cessation
- 2001-08-15 ES ES01964084T patent/ES2284678T3/es not_active Expired - Lifetime
- 2001-08-15 WO PCT/US2001/025662 patent/WO2002014499A2/en active IP Right Grant
- 2001-08-15 MX MXPA03001468A patent/MXPA03001468A/es not_active Application Discontinuation
- 2001-08-15 AU AU2001284977A patent/AU2001284977B2/en not_active Ceased
- 2001-08-15 DE DE60128701T patent/DE60128701T2/de not_active Expired - Fee Related
- 2001-08-15 AU AU8497701A patent/AU8497701A/xx active Pending
-
2007
- 2007-02-01 US US11/701,883 patent/US20080254506A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60128701T2 (de) | 2008-02-07 |
WO2002014499A9 (en) | 2002-04-18 |
ES2284678T3 (es) | 2007-11-16 |
AU8497701A (en) | 2002-02-25 |
US20080254506A1 (en) | 2008-10-16 |
EP1311663A2 (de) | 2003-05-21 |
AU2001284977B2 (en) | 2005-11-24 |
DE60128701D1 (en) | 2007-07-12 |
WO2002014499A2 (en) | 2002-02-21 |
EP1311663B1 (de) | 2007-05-30 |
CA2418725A1 (en) | 2002-02-21 |
WO2002014499A3 (en) | 2002-10-31 |
MXPA03001468A (es) | 2004-05-04 |
JP2004519215A (ja) | 2004-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE363531T1 (de) | Claudin polypeptide | |
NO20041917L (no) | Spesifikke midler som binder humant angiopoietin-2 | |
WO2003011115A3 (en) | Peptide-based multimeric targeted contrast agents | |
NO20034056D0 (no) | Proliferative sykdommer | |
DE60226724D1 (de) | Antimikrobielles polypeptid | |
MXPA02004666A (es) | Gelatinas recombinantes. | |
CY1111622T1 (el) | Ανθρωποποιημενοι ανταγωνιστες anti-cmet | |
BR0309665A (pt) | Tratamento de deficiência de alfa-galactosidase a | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
DE60108857D1 (de) | Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren | |
DE60326623D1 (de) | P53-bindendes polypeptid | |
DE60230194D1 (de) | Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicycloä2.2.1ühept-1-ylmethanesulphonamide-familie | |
EA200601220A1 (ru) | Анти-trkc антитела-агонисты и способы их применения | |
DE60224667D1 (de) | Perylenequinonen zur anwendung als sonosensitizer | |
ATE406438T1 (de) | Menschliches homolog aus der familie der metalloproteasen | |
MXPA03008039A (es) | Polipeptidos de serpina humanos. | |
BR0206917A (pt) | Uso de antagonistas de mglur5 para o tratamento de condições prurìticas | |
WO2003100001A3 (en) | Claudin polypeptides, polynucleotides, and methods of making and use thereof | |
DE60221501D1 (de) | Bfit (brown fat inducible thioesterase) polypeptide und polynukleotide und ihre verwendung | |
MXPA06013176A (es) | Dominios semejantes al factor de crecimiento epidermico de mucina 3. | |
DE60118898D1 (de) | Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen | |
DE60211227D1 (de) | Androgenrezeptor-Komplex assoziiertes Protein | |
DE602004012759D1 (de) | Behandlung von fibrosen | |
DE60229871D1 (de) | Moraxella (branhamella) catarrhalis polypeptide | |
TR199902914T2 (xx) | �zole sistolik hipertansiyonu tedavi y�ntemi. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |